CA2483697A1 - Nanoparticle probes with raman spectroscopic fingerprints for analyte detection - Google Patents
Nanoparticle probes with raman spectroscopic fingerprints for analyte detection Download PDFInfo
- Publication number
- CA2483697A1 CA2483697A1 CA002483697A CA2483697A CA2483697A1 CA 2483697 A1 CA2483697 A1 CA 2483697A1 CA 002483697 A CA002483697 A CA 002483697A CA 2483697 A CA2483697 A CA 2483697A CA 2483697 A1 CA2483697 A1 CA 2483697A1
- Authority
- CA
- Canada
- Prior art keywords
- substrate
- raman
- particle
- oligonucleotides
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention encompasses reagents comprising particles with at least one Raman dye and a specific binding members bound thereto and methods of using such reagents. The invention also encompasses reagents of a specific binding member and two or more different Raman dyes and methods for using such reagents. New types of particle probes having a specific binding member bound thereto are described. These reagents are used in a novel detection strategy that utilizes the catalytic properties of the Au nanoparticles to generate a silver coating that can behave as a surface-enhanced Raman scattering (SERS) promoter for the dye-labeled particles that have been captured by target and an underlying chip in microarray format. The strategy provides the high sensitivity and high selectivity attributes of grey-scale scanometric detection but provides a route to multiplexing and ratioing capabilities since a very large number of probes can be designed based upon the concept of using a Raman tag as a spectroscopic fingerprint in detection. These spectra are used as fingerprints to differentiate oligonucleotide or other targets in one solution. This method has been used to distinguish six dissimilar DNA targets with six Raman labeled nanoparticle probes, and also two RNA targets with single nucleotide polymorphisms (SNPs).
Claims (88)
1. A reagent comprising a particle having bound there to at least one Raman label and a specific binding member wherein the Raman label can be activated to provide a SERS effect.
2. The reagent of claim 1 wherein the particle has two or more different Raman labels.
3. The reagent of claim 1 wherein the specific binding member is a DNA, RNA, polypeptide, antibody, antigen, carbohydrate, protein, peptide, amino acid, carbohydrate, hormone, steroid, vitamin, drug, virus, polysaccharides, lipids, lipopolysaccharides, glycoproteins, lipoproteins, nucleoproteins, oligonucleotides, antibodies, immunoglobulins, albumin, hemoglobin, coagulation factors, peptide and protein hormones, non-peptide hormones, interleukins, interferons, cytokines, peptides comprising a tumor-specific epitope, cells, cell-surface molecules, microorganisms, fragments, portions, components or products of microorganisms, small organic molecules, nucleic acids and oligonucleotides, metabolites of or antibodies to any of the above substances.
4. The reagent of claim 3 wherein nucleic acids and oligonucleotides comprise genes, viral RNA and DNA, bacterial DNA, fungal DNA, mammalian DNA, cDNA, mRNA, RNA and DNA fragments, oligonucleotides, synthetic oligonucleotides, modified oligonucleotides, single-stranded and double-stranded nucleic acids, natural and synthetic nucleic acids.
5. The reagent of claim 1 wherein the particle is a gold, Ag, Cu, Pt, Ag/Au, Pt/Au, Cu/Au coreshell and alloy particles.
6. The reagent of claim 1 wherein the particle is a nanoparticle.
7. The reagent of claim 1 wherein the particle is a metallic nanoparticle.
8. The reagent of claim 1 wherein the particle is a gold nanoparticle.
9. The reagent of claim 1 wherein the Raman label is directly bound to the particle.
10. The reagent of claim 9 wherein the Raman label is indirectly bound to the particle.
11. The reagent of claim 1 wherein at least some of the Raman labels are conjugated to the specific binding pair member.
12. The reagent of claim 11 wherein the conjugate is covalently bound to the particle.
13. The reagent of claim 1 wherein the specific binding pair member is covalently bound to the particle via a functional group.
14. The reagent of claim 1 wherein the Raman label is activated by a staining material.
15. The reagent of claim 1 wherein the staining material comprises silver, gold or copper stain.
16. A reagent comprising a specific binding member having two or more different Raman labels bound thereto.
17. The reagent of claim 16 wherein the specific binding member comprises a member of a specific binding pair selected from the group consisting of antigen and antibody-specific binding pairs, biotin and avidin binding pairs, carbohydrate and lectin bind pairs, complementary nucleotide sequences, complementary peptide sequences, effector and receptor molecules, enzyme cofactor and enzymes, and enzyme inhibitors and enzymes.
18. The reagent of claim 16 wherein the specific binding member is a DNA, RNA, polypeptide, antibody, antigen, carbohydrate, protein, peptide, amino acid, carbohydrate, hormone, steroid, vitamin, drug, virus, polysaccharides, lipids, lipopolysaccharides, glycoproteins, lipoproteins, nucleoproteins, oligonucleotides, antibodies, immunoglobulins, albumin, hemoglobin, coagulation factors, peptide and protein hormones, non-peptide hormones, interleukins, interferons, cytokines, peptides comprising a tumor-specific epitope, cells, cell-surface molecules, microorganisms, fragments, portions, components or products of microorganisms, small organic molecules, nucleic acids and oligonucleotides, metabolites of or antibodies to any of the above substances.
19. The reagent of claim 18 wherein nucleic acids and oligonucleotides comprise genes, viral RNA and DNA, bacterial DNA, fungal DNA, mammalian DNA, cDNA, mRNA, RNA and DNA fragments, oligonucleotides, synthetic oligonucleotides, modified oligonucleotides, single-stranded and double-stranded nucleic acids, natural and synthetic nucleic acids.
20. A reagent of claim 16 wherein the specific binding member is a DNA, RNA, antibody, antigen, polypeptide or carbohydrate.
21. A method for detecting an analyte comprising:
(a) forming a complex of the reagent of claim 1 and the analyte;
(b) binding the complex to a substrate;
(c) staining the complex on the substrate to activate the SERS effect in the Raman label; and (d) measuring the SERS effect.
(a) forming a complex of the reagent of claim 1 and the analyte;
(b) binding the complex to a substrate;
(c) staining the complex on the substrate to activate the SERS effect in the Raman label; and (d) measuring the SERS effect.
22. The method of claim 21 wherein the complex is bound to the substrate through one or more specific binding substances.
23. A method for detecting an analyte comprising:
(a) binding the analyte to a substrate;
(b) complexing the reagent of claim 1 with the analyte on the substrate (c) staining the complex on the substrate to activate the SERS effect in the Raman label;
(d) measuring the SRS effect.
(a) binding the analyte to a substrate;
(b) complexing the reagent of claim 1 with the analyte on the substrate (c) staining the complex on the substrate to activate the SERS effect in the Raman label;
(d) measuring the SRS effect.
24. The method of claim 23 wherein the reagent is indirectly bound to the analyte on the substrate through one or more specific binding substances.
25. The method of claim 21 or 23 wherein the target analyte comprises an antibody, an antigen, a hapten, a receptor, a ligand, a protein, a peptide, a polypeptide, a nucleic acid, a membrane or membrane fraction, a lipid, a membrane-protein complex, a carbohydrate, a virus, a cell or macromolecule or molecular complex.
26. The method of claim 21 or 23 wherein the specific binding member comprises an antibody, an antigen, a receptor, a ligand, a protein, a polypeptide, small molecule or a nucleic acid.
27. The method of claims 21 or 23 wherein the specific binding member comprises a member of a specific binding pair selected from the group consisting of antigen and antibody-specific binding pairs, biotin and avidin binding pairs, carbohydrate and lectin bind pairs, complementary nucleotide sequences, complementary peptide sequences, effector and receptor molecules, enzyme cofactor and enzymes, and enzyme inhibitors and enzymes.
28. The method of claim 27 wherein the specific binding member is a DNA, RNA, polypeptide, antibody, antigen, carbohydrate, protein, peptide, amino acid, carbohydrate, hormone, steroid, vitamin, drug, virus, polysaccharides, lipids, lipopolysaccharides, glycoproteins, lipoproteins, nucleoproteins, oligonucleotides, antibodies, immunoglobulins, albumin, hemoglobin, coagulation factors, peptide and protein hormones, non-peptide hormones, interleukins, interferons, cytokines, peptides comprising a tumor-specific epitope, cells, cell-surface molecules, microorganisms, fragments, portions, components or products of microorganisms, small organic molecules, nucleic acids and oligonucleotides, metabolites of or antibodies to any of the above substances.
29. The method of claim 28 wherein nucleic acids and oligonucleotides comprise genes, viral RNA and DNA, bacterial DNA, fungal DNA, mammalian DNA, cDNA, mRNA, RNA and DNA fragments, oligonucleotides, synthetic oligonucleotides, modified oligonucleotides, single-stranded and double-stranded nucleic acids, natural and synthetic nucleic acids.
30. The method of claims 21 or 23 wherein the substrate has a plurality of different first specific binding members attached thereto in an array to allow for the detection of multiple types of target analytes.
31. The method of claims 21 or 23 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
32. A method for detecting for the presence or absence of one or more target analytes in a sample, the target analytes having at least two binding sites, said method comprising:
providing a substrate having bound thereto one or more types of a first specific binding member for immobilizing the target analytes onto said substrate;
providing one or more types of particles, each type of particles having bound thereto (a) one or more Raman labels; and (b) a second specific binding member for binding to a specific target analyte, wherein (i) the Raman active labels bound to each type of particle is different and serves as an identifier for a specific target analyte; and (ii) the second specific binding member bound to each type of particle is different and is targeted to a specific target analyte;
contacting the particles, the sample and the substrate under conditions effective for specific binding interactions between the target analyte and first and second specific binding member so as to form a test substrate having particles complexed thereto in the presence of one or more target analytes in the sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as an indication of the presence of one or more target analytes in the sample by obtaining and analyzing a SERS spectrum.
providing a substrate having bound thereto one or more types of a first specific binding member for immobilizing the target analytes onto said substrate;
providing one or more types of particles, each type of particles having bound thereto (a) one or more Raman labels; and (b) a second specific binding member for binding to a specific target analyte, wherein (i) the Raman active labels bound to each type of particle is different and serves as an identifier for a specific target analyte; and (ii) the second specific binding member bound to each type of particle is different and is targeted to a specific target analyte;
contacting the particles, the sample and the substrate under conditions effective for specific binding interactions between the target analyte and first and second specific binding member so as to form a test substrate having particles complexed thereto in the presence of one or more target analytes in the sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as an indication of the presence of one or more target analytes in the sample by obtaining and analyzing a SERS spectrum.
33. The method of claim 32 wherein the substrate has a plurality of different first specific binding members attached thereto in an array to allow for the detection of multiple types of target analytes.
34. The method of claim 32 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
35. The method of claim 32 wherein at least a portion of the Raman labels is conjugated to the specific binding member.
36. The method of claim 32 wherein the Raman labels is conjugated to an oligonucleotide.
37. The method of claim 33 wherein the oligonucleotide is a polyadenosine or polythymidine.
38. The method of claim 32 wherein the oligonucleotide is not complementary to any target nucleic acid.
39. The method of claim 32 wherein the particle is a nanoparticle.
40. The method of claim 32 wherein the particle is a metallic nanoparticle.
41. The method of claim 32 wherein the Raman label is conjugated to the specific binding pair member.
42. The method of claim 41 wherein the conjugate is covalently bound to the particle.
43. The method of claim 32 wherein the specific binding member is a DNA, RNA, polypeptide, antibody, antigen, carbohydrate, protein, peptide, amino acid, carbohydrate, hormone, steroid, vitamin, drug, virus, polysaccharides, lipids, lipopolysaccharides, glycoproteins, lipoproteins, nucleoproteins, oligonucleotides, antibodies, immunoglobulins, albumin, hemoglobin, coagulation factors, peptide and protein hormones, non-peptide hormones, interleukins, interferons, cytokines, peptides comprising a tumor-specific epitope, cells, cell-surface molecules, microorganisms, fragments, portions, components or products of microorganisms, small organic molecules, nucleic acids and oligonucleotides, metabolites of or antibodies to any of the above substances.
44. The method of claim 43 wherein nucleic acids and oligonucleotides comprise genes, viral RNA and DNA, bacterial DNA, fungal DNA, mammalian DNA (e.g., human DNA), cDNA, mRNA, RNA and DNA fragments, oligonucleotides, synthetic oligonucleotides, modified oligonucleotides, single-stranded and double-stranded nucleic acids, natural and synthetic nucleic acids.
45. The reagent of claim 32 wherein the specific binding member comprises a member of a specific binding pair selected from the group consisting of antigen and antibody-specific binding pairs, biotin and avidin binding pairs, carbohydrate and lectin bind pairs, complementary nucleotide sequences, complementary peptide sequences, effector and receptor molecules, enzyme cofactor and enzymes, and enzyme inhibitors and enzymes.
46. A method for detecting for the presence or absence of one or more target nucleic acids in a sample, the sequence of the nucleic acid having at least two portions, said method comprising:
providing a substrate having oligonucleotides bound thereto, the oligonucleotides bound to the substrate having a sequence that is complementary to a first portion of a specific nucleic acid target;
providing one or more types of particles, each type of particles comprising oligonucleotides and at least one or more Raman active labels bound thereto, wherein (i) at least some of the oligonucleotides attached to each type of particle have a sequence that is complementary to a second portion of the sequence of a specific target nucleic acid; and (ii) the Raman labels bound to each type of particles is different and serves as an identifier for a specific target nucleic acid, said Raman label comprising at least one Raman label.
contacting the particles, the substrate, and the sample under conditions effective for hybridization of the oligonucleotides bound to the substrate with the first portion of the nucleic acid and for hybridization of the oligonucleotides attached to the particle with the second portion of the nucleic acid so as to form a test substrate having one or more particle complexes bound thereto when one or more target nucleic acids are present in said sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as an indication of the presence of one or more target nucleic acids in the sample by obtaining and analyzing a SERS spectrum.
providing a substrate having oligonucleotides bound thereto, the oligonucleotides bound to the substrate having a sequence that is complementary to a first portion of a specific nucleic acid target;
providing one or more types of particles, each type of particles comprising oligonucleotides and at least one or more Raman active labels bound thereto, wherein (i) at least some of the oligonucleotides attached to each type of particle have a sequence that is complementary to a second portion of the sequence of a specific target nucleic acid; and (ii) the Raman labels bound to each type of particles is different and serves as an identifier for a specific target nucleic acid, said Raman label comprising at least one Raman label.
contacting the particles, the substrate, and the sample under conditions effective for hybridization of the oligonucleotides bound to the substrate with the first portion of the nucleic acid and for hybridization of the oligonucleotides attached to the particle with the second portion of the nucleic acid so as to form a test substrate having one or more particle complexes bound thereto when one or more target nucleic acids are present in said sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as an indication of the presence of one or more target nucleic acids in the sample by obtaining and analyzing a SERS spectrum.
47. The method according to claim 46 wherein the Raman label is conjugated to at least a portion of the oligonucleotides.
48. The method of claim 46 wherein the substrate has a plurality of different first specific binding members attached thereto in an array to allow for the detection of multiple types of target analytes.
49. The method of claim 46 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
50. The method of claim 46 wherein at least a portion of the Raman labels is conjugated to the specific binding member.
51. The method of claim 46 wherein the Raman labels is conjugated to an oligonucleotide.
52. The method of claim 51 wherein the oligonucleotide is a polyadenosine or polythymidine.
53. The method of claim 51 wherein the oligonucleotide is not complementary to any target nucleic acid.
54. The reagent of claim 46 wherein the particle is a nanoparticle.
55. The reagent of claim 46 wherein the particle is a metallic nanoparticle.
56. The reagent of claim 46 wherein the Raman label is conjugated to the specific binding pair member.
57. The reagent of claim x wherein the conjugate is covalently bound to the particle.
58. A method for detecting for the presence or absence of one or more target nucleic acids in a sample, the sequence of the nucleic acid having at least two portions, said method comprising:
providing a substrate having oligonucleotides bound thereto, the oligonucleotides bound to the substrate having a sequence that is complementary to a first portion of the nucleic acid;
providing one or more types of particles, each type of particles comprising oligonucleotides bound thereto and a Raman label bound to at least a portion of the oligonucleotides, wherein (i) at least some of the oligonucleotides attached to the particle have a sequence that is complementary to a second portion of the nucleic acid;
and (ii) the Raman labels bound to each type of particles serves as an identifier for a specific target nucleic acid, said Raman label comprising at least one Raman label providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, the substrate, and the sample under conditions effective for hybridization of the oligonucleotides bound to the substrate with the first portion of the nucleic acid and for hybridization of the oligonucleotides attached to the particle with the second portion of the nucleic acid so as to form a test substrate having a particle complex bound thereto when said target nucleic acid is present in said sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complex on said detection substrate as an indication of the presence of the target nucleic acid in the sample by obtaining and analyzing a SERS spectrum.
providing a substrate having oligonucleotides bound thereto, the oligonucleotides bound to the substrate having a sequence that is complementary to a first portion of the nucleic acid;
providing one or more types of particles, each type of particles comprising oligonucleotides bound thereto and a Raman label bound to at least a portion of the oligonucleotides, wherein (i) at least some of the oligonucleotides attached to the particle have a sequence that is complementary to a second portion of the nucleic acid;
and (ii) the Raman labels bound to each type of particles serves as an identifier for a specific target nucleic acid, said Raman label comprising at least one Raman label providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, the substrate, and the sample under conditions effective for hybridization of the oligonucleotides bound to the substrate with the first portion of the nucleic acid and for hybridization of the oligonucleotides attached to the particle with the second portion of the nucleic acid so as to form a test substrate having a particle complex bound thereto when said target nucleic acid is present in said sample;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complex on said detection substrate as an indication of the presence of the target nucleic acid in the sample by obtaining and analyzing a SERS spectrum.
59. The method according to claim 58 wherein the Raman label is conjugated to at least a portion of the oligonucleotides.
60. The method of claim 58 wherein the substrate has a plurality of different oligonucleotides attached thereto in an array to allow for the detection of multiple types of target nucleic acids or portions of a target nucleic acid.
61. The method of claim 58 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
62. The method of claim 58 wherein the particle is a nanoparticle.
63. The method of claim 58 wherein the particle is a metallic nanoparticle.
64. The method of claim 63 wherein the particle is a gold nanoparticle.
65. A method for screening one or more molecules to determine whether the molecule is a ligand to one or more specific receptors, the molecules are present in a sample, said method comprising:
providing a substrate having bound thereto one or more specific receptors;
providing one or more types of conjugates comprising particles, oligonucleotides bound to the particles, a Raman active label bound to a portion of the oligonucleotides, and the molecule from said sample bound to a portion of the oligonucleotides of a specific type of conjugate, wherein said Raman active label comprising at least one Raman active molecule providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, sample and substrate under conditions effective for specific binding interactions between the molecule bound to the particles with the specific receptor bound to the substrate so as to form a test substrate having particles complexed thereto when the molecule is a ligand to a specific receptor;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as a confirmation of a ligand to a specific receptor by obtaining and analyzing a SERS
spectrum.
providing a substrate having bound thereto one or more specific receptors;
providing one or more types of conjugates comprising particles, oligonucleotides bound to the particles, a Raman active label bound to a portion of the oligonucleotides, and the molecule from said sample bound to a portion of the oligonucleotides of a specific type of conjugate, wherein said Raman active label comprising at least one Raman active molecule providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, sample and substrate under conditions effective for specific binding interactions between the molecule bound to the particles with the specific receptor bound to the substrate so as to form a test substrate having particles complexed thereto when the molecule is a ligand to a specific receptor;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as a confirmation of a ligand to a specific receptor by obtaining and analyzing a SERS
spectrum.
66. The method of claim 65 wherein the substrate has a plurality of different receptors attached thereto in an array to allow for the detection of multiple types of molecules.
67. The method of claim 65 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
68. The method of claim 65 wherein the particle is a nanoparticle.
69. The method of claim 65 wherein the particle is a metallic nanoparticle.
70. The method of claim 69 wherein the particle is a gold nanoparticle.
71. A method for screening one or more molecules to determine whether the molecule is a ligand to one or more specific receptors, the molecules are present in a sample, said method comprising:
providing a substrate having bound thereto one or more specific receptors;
providing a molecule modified with a first member of a specific binding pair;
providing one or more types of conjugates, each type of conjugate comprising a particle, one or more Raman active labels bound to the particle, and a second member of the specific binding pair bound to the particle, wherein said Raman active label comprising at least one Raman active molecule providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, sample and substrate under conditions effective for specific binding interactions between the molecule with the specific receptor bound to the substrate and between the first and second members of the specific binding pair so as to form a test substrate having particles complexed thereto when the molecule is a ligand to a specific receptor;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as a confirmation of a ligand to a specific receptor by obtaining and analyzing a SERS
spectrum.
71. The method of claim 70 wherein the substrate has a plurality of different receptors attached thereto in an array to allow for the detection of multiple types of molecules.
providing a substrate having bound thereto one or more specific receptors;
providing a molecule modified with a first member of a specific binding pair;
providing one or more types of conjugates, each type of conjugate comprising a particle, one or more Raman active labels bound to the particle, and a second member of the specific binding pair bound to the particle, wherein said Raman active label comprising at least one Raman active molecule providing a detectable or measurable Raman scattering signal when illuminated by radiation capable of inducing a Raman scattering;
contacting the particles, sample and substrate under conditions effective for specific binding interactions between the molecule with the specific receptor bound to the substrate and between the first and second members of the specific binding pair so as to form a test substrate having particles complexed thereto when the molecule is a ligand to a specific receptor;
contacting the test substrate with a staining material to produce a detection substrate having a surface capable of causing surface-enhanced Raman scattering (SERS);
and determining for the presence of said particle complexes on said detection substrate as a confirmation of a ligand to a specific receptor by obtaining and analyzing a SERS
spectrum.
71. The method of claim 70 wherein the substrate has a plurality of different receptors attached thereto in an array to allow for the detection of multiple types of molecules.
72. The method of claim 70 wherein the substrate comprises a glass slide, microplate well, beads, polymer membrane, or optical fiber.
73. The method of claim 70 wherein the particle is a gold, Ag, Cu, Pt, Ag/Au, Pt/Au, Cu/Au coreshell and alloy particles.
74. The method of claim 70 wherein the particle is a nanoparticle.
75. The method of claim 70 wherein the particle is a metallic nanoparticle.
76. The method of claim 75 wherein the particle is a gold nanoparticle.
77. The method of claim 70 wherein the Raman label is directly bound to the particle.
78. The method of claim 70 wherein the Raman label is indirectly bound to the particle.
79. The method of claim 70 wherein the Raman label is activated by a staining material.
80. The method of claim 79 wherein the staining material comprises silver, gold or copper stain.
81. A test kit comprising the reagent of claim 1 in one container and a Raman enhancer stain in another container.
82. A test kit comprising the reagent of claim 1 in one container and a silver, gold or copper stain Raman enhancer in another container.
83. A test kit comprising the reagent of claim 16 in one container and a Raman enhancer stain in another container.
84. A test kit comprising the reagent of claim 16 in one container and a silver, gold or copper stain Raman enhancer in another container.
85. A fiber optic detection device comprising a bundle of optical fibers terminating with ends of the optical fiber wherein a plurality of the optical fibers have a reagent of claim 1 located at the ends of the optical fiber.
86. The fiber optic detection device of claim 85 wherein two or more of the reagents of claim 1 at the ends of the optical fiber have different specific binding member and different Raman labels.
87. A fiber optic detection device comprising a bundle of optical fibers terminating with ends of the optical fiber wherein a plurality of the optical fibers have a reagent of claim 16 located at the ends of the optical fiber.
88. The fiber optic detection device of claim 85 wherein two or more of the reagents of claim 16 at the ends of the optical fiber have different specific binding member and different Raman labels.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37853802P | 2002-05-07 | 2002-05-07 | |
US60/378,538 | 2002-05-07 | ||
US38363002P | 2002-05-28 | 2002-05-28 | |
US60/383,630 | 2002-05-28 | ||
US10/172,428 US20030211488A1 (en) | 2002-05-07 | 2002-06-14 | Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection |
US10/172,428 | 2002-06-14 | ||
PCT/US2003/014100 WO2003095973A2 (en) | 2002-05-07 | 2003-05-07 | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2483697A1 true CA2483697A1 (en) | 2003-11-20 |
CA2483697C CA2483697C (en) | 2010-03-30 |
Family
ID=29407691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2483697A Expired - Fee Related CA2483697C (en) | 2002-05-07 | 2003-05-07 | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
Country Status (7)
Country | Link |
---|---|
US (2) | US20030211488A1 (en) |
EP (1) | EP1499889B1 (en) |
JP (1) | JP2005524849A (en) |
AT (1) | ATE515698T1 (en) |
AU (1) | AU2003237180B2 (en) |
CA (1) | CA2483697C (en) |
WO (1) | WO2003095973A2 (en) |
Families Citing this family (161)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169556B2 (en) * | 1996-07-29 | 2007-01-30 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6750016B2 (en) * | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US7098320B1 (en) | 1996-07-29 | 2006-08-29 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
US6984491B2 (en) * | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6506564B1 (en) * | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6974669B2 (en) * | 2000-03-28 | 2005-12-13 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified nanoparticles |
US20050037397A1 (en) * | 2001-03-28 | 2005-02-17 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
CA2396113C (en) * | 2000-01-13 | 2009-04-07 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
ATE324465T1 (en) * | 2000-07-11 | 2006-05-15 | Univ Northwestern | DETECTION METHOD USING INCREASED SILVER TINTING |
US20060040286A1 (en) * | 2001-03-28 | 2006-02-23 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
US20030113740A1 (en) * | 2001-04-26 | 2003-06-19 | Mirkin Chad A. | Oligonucleotide-modified ROMP polymers and co-polymers |
US7238472B2 (en) * | 2001-05-25 | 2007-07-03 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
US7147687B2 (en) * | 2001-05-25 | 2006-12-12 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
US7160577B2 (en) | 2002-05-02 | 2007-01-09 | Micron Technology, Inc. | Methods for atomic-layer deposition of aluminum oxides in integrated circuits |
US20030211488A1 (en) * | 2002-05-07 | 2003-11-13 | Northwestern University | Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection |
AU2003247788B2 (en) * | 2002-07-02 | 2007-04-19 | Nanosphere Inc. | Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
EP1387169B1 (en) * | 2002-08-02 | 2006-05-24 | Sony Deutschland GmbH | Method of attaching hydrophilic species to hydrophilic macromolecules and immobilizing the hydrophilic macromolecules on a hydrophobic surface |
US8020433B2 (en) * | 2003-03-25 | 2011-09-20 | Tearlab Research, Inc. | Systems and methods for a sample fluid collection device |
US7810380B2 (en) | 2003-03-25 | 2010-10-12 | Tearlab Research, Inc. | Systems and methods for collecting tear film and measuring tear film osmolarity |
WO2004053105A2 (en) * | 2002-12-12 | 2004-06-24 | Nanosphere, Inc. | Direct snp detection with unamplified dna |
WO2005001143A2 (en) * | 2003-02-27 | 2005-01-06 | Nanosphere, Inc. | Label-free gene expression profiling with universal nanoparticle probes in microarray assay format |
US7019828B2 (en) * | 2003-03-12 | 2006-03-28 | Intel Corporation | Chemical enhancement in surface enhanced raman scattering using lithium salts |
US20050250094A1 (en) * | 2003-05-30 | 2005-11-10 | Nanosphere, Inc. | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes |
WO2005001113A2 (en) * | 2003-06-27 | 2005-01-06 | Thomas Jefferson University | Methods for detecting nucleic acid variations |
US20070134733A1 (en) * | 2003-07-10 | 2007-06-14 | Parallax Biosystems, Inc. | Raman signature probes and their use in the detection and imaging of molecular processes and structures |
GB0319949D0 (en) * | 2003-08-26 | 2003-09-24 | Univ Strathclyde | Nucleic acid sequence identification |
US20050064435A1 (en) * | 2003-09-24 | 2005-03-24 | Xing Su | Programmable molecular barcodes |
EP1678495A4 (en) * | 2003-10-20 | 2007-06-27 | Univ California | Nanoscale transduction systems for detecting molecular interactions |
EP1698897B1 (en) * | 2003-12-19 | 2010-03-17 | Nippon Steel Kankyo Engineering Co., Ltd. | Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor |
US20050147976A1 (en) * | 2003-12-29 | 2005-07-07 | Xing Su | Methods for determining nucleotide sequence information |
US7361410B2 (en) * | 2003-12-29 | 2008-04-22 | Intel Corporation | External modification of composite organic inorganic nanoclusters comprising raman active organic compound |
US20080076119A9 (en) * | 2003-12-29 | 2008-03-27 | Lei Sun | Composite organic inorganic nanoclusters |
US20050147963A1 (en) * | 2003-12-29 | 2005-07-07 | Intel Corporation | Composite organic-inorganic nanoparticles and methods for use thereof |
US20050191665A1 (en) * | 2003-12-29 | 2005-09-01 | Xing Su | Composite organic-inorganic nanoclusters |
US20050148098A1 (en) * | 2003-12-30 | 2005-07-07 | Xing Su | Methods for using raman spectroscopy to obtain a protein profile of a biological sample |
US20050148100A1 (en) * | 2003-12-30 | 2005-07-07 | Intel Corporation | Methods and devices for using Raman-active probe constructs to assay biological samples |
US7736890B2 (en) * | 2003-12-31 | 2010-06-15 | President And Fellows Of Harvard College | Assay device and method |
WO2005069006A1 (en) * | 2004-01-06 | 2005-07-28 | Bwt Property Inc. | Novel antibody mediated surface enhanced raman scattering (sers) immunoassay and multiplexing schemes |
US7422696B2 (en) * | 2004-02-20 | 2008-09-09 | Northwestern University | Multicomponent nanorods |
US20050225758A1 (en) * | 2004-03-23 | 2005-10-13 | Knopp Kevin J | Raman optical identification tag |
DE102004015272A1 (en) * | 2004-03-29 | 2005-11-03 | Infineon Technologies Ag | Biosensor to determine the presence of DNA comprises trap molecules that hybridize with the target molecules over photo diode detector |
US7351591B2 (en) * | 2004-03-30 | 2008-04-01 | Intel Corporation | Surface modification of metals for biomolecule detection using surface enhanced Raman scattering (SERS) |
US20050221507A1 (en) * | 2004-03-30 | 2005-10-06 | Intel Corporation | Method to detect molecular binding by surface-enhanced Raman spectroscopy |
EP1582599A1 (en) * | 2004-03-31 | 2005-10-05 | Takara Bio Inc. | Method for purifying microbeads |
US7226794B2 (en) * | 2004-04-14 | 2007-06-05 | Agilent Technologies, Inc. | Surface-enhanced Raman spectroscopy for biosensor systems and methods for determining the presence of biomolecules |
AU2005323511A1 (en) * | 2004-04-23 | 2006-07-13 | Becton, Dickinson And Company | Surface enhanced spectroscpy-active composite nanop articles and their application in analysis and diagnosis |
EP1771583A2 (en) * | 2004-07-26 | 2007-04-11 | Nanosphere, Inc. | Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture |
US20070048797A1 (en) * | 2004-08-11 | 2007-03-01 | Xing Su | Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules |
US20060046311A1 (en) * | 2004-08-26 | 2006-03-02 | Intel Corporation | Biomolecule analysis using Raman surface scanning |
US7776547B2 (en) * | 2004-08-26 | 2010-08-17 | Intel Corporation | Cellular analysis using Raman surface scanning |
US7588988B2 (en) | 2004-08-31 | 2009-09-15 | Micron Technology, Inc. | Method of forming apparatus having oxide films formed using atomic layer deposition |
US20080268431A1 (en) * | 2004-09-14 | 2008-10-30 | Jin-Ho Choy | Information Code System Using Dna Sequences |
WO2006037036A2 (en) * | 2004-09-27 | 2006-04-06 | Purdue Research Foundation | Quantitative proteomics with isotopic substituted raman active labeling |
US7285427B2 (en) * | 2004-10-06 | 2007-10-23 | General Electric Company | Raman-active particles and methods of making and using them |
US7393692B2 (en) * | 2004-10-18 | 2008-07-01 | Real-Time Analyzers, Inc. | SERS method for rapid pharmacokinetic analysis of drugs in saliva |
US7393691B2 (en) * | 2004-10-18 | 2008-07-01 | Real-Time Analyzers, Inc. | SERS method and apparatus for rapid extraction and analysis of drugs in saliva |
US7583379B2 (en) | 2005-07-28 | 2009-09-01 | University Of Georgia Research Foundation | Surface enhanced raman spectroscopy (SERS) systems and methods of use thereof |
US7738096B2 (en) | 2004-10-21 | 2010-06-15 | University Of Georgia Research Foundation, Inc. | Surface enhanced Raman spectroscopy (SERS) systems, substrates, fabrication thereof, and methods of use thereof |
AU2005299747B2 (en) * | 2004-10-21 | 2010-04-08 | Pharma Diagnostics N.V. | Stable metal/conductive polymer composite colloids and methods for making and using the same |
WO2006060171A2 (en) * | 2004-11-16 | 2006-06-08 | Board Of Regents, The University Of Texas System | Methods and compositions related to phage-nanoparticle assemblies |
EP1825269A4 (en) * | 2004-12-13 | 2012-06-06 | Univ South Carolina | Surface enhanced raman spectroscopy using shaped gold nanoparticles |
US7485471B1 (en) * | 2004-12-17 | 2009-02-03 | Intel Corporation | Detection of enhanced multiplex signals by surface enhanced Raman spectroscopy |
US20060134806A1 (en) * | 2004-12-20 | 2006-06-22 | General Electric Company | Method of separating unattached Raman-active tag from bioassay or other reaction mixture |
US20060147941A1 (en) * | 2004-12-30 | 2006-07-06 | Intel Corporation | Methods and apparatus for SERS assay of biological analytes |
US7687409B2 (en) | 2005-03-29 | 2010-03-30 | Micron Technology, Inc. | Atomic layer deposited titanium silicon oxide films |
US7662729B2 (en) | 2005-04-28 | 2010-02-16 | Micron Technology, Inc. | Atomic layer deposition of a ruthenium layer to a lanthanide oxide dielectric layer |
US7572695B2 (en) | 2005-05-27 | 2009-08-11 | Micron Technology, Inc. | Hafnium titanium oxide films |
JP2006349462A (en) * | 2005-06-15 | 2006-12-28 | Canon Inc | Surface reinforcing raman spectroscopic analyzing jig and its manufacturing method |
US20070154903A1 (en) * | 2005-06-23 | 2007-07-05 | Nanosphere, Inc. | Selective isolation and concentration of nucleic acids from complex samples |
US20070134815A1 (en) * | 2005-07-11 | 2007-06-14 | Danielle Chamberlin | Sensitivity enhancement of POCT devices using gold and silver nanoparticles on substrates containing nanostructures or nanoparticles that interact with labeling particles |
US7927948B2 (en) | 2005-07-20 | 2011-04-19 | Micron Technology, Inc. | Devices with nanocrystals and methods of formation |
US7575978B2 (en) | 2005-08-04 | 2009-08-18 | Micron Technology, Inc. | Method for making conductive nanoparticle charge storage element |
JP2009505106A (en) * | 2005-08-19 | 2009-02-05 | ナノスフェアー インコーポレイテッド | Method for preparing a hybrid substrate comprising DNA and antibodies and use thereof |
US7410763B2 (en) * | 2005-09-01 | 2008-08-12 | Intel Corporation | Multiplex data collection and analysis in bioanalyte detection |
KR100650522B1 (en) | 2005-09-15 | 2006-11-27 | 재단법인서울대학교산학협력재단 | A new label-free high throughput screening method by using sers spectroscopic encoded bead and dielectrophoresis |
US20070072309A1 (en) * | 2005-09-29 | 2007-03-29 | General Electric Company | Analytical compositions including nanometer-sized transducers, methods to make thereof, and devices therefrom |
JPWO2007049508A1 (en) * | 2005-10-24 | 2009-04-30 | 株式会社アイ・ピー・ビー | Long-chain DNA base sequence analysis apparatus and method |
EP1948829A4 (en) * | 2005-11-15 | 2009-08-26 | Becton Dickinson Co | Sers-based methods for detection of bioagents |
US20070155022A1 (en) * | 2005-12-30 | 2007-07-05 | Mineo Yamakawa | Degenerate binding detection and protein identification using Raman spectroscopy nanoparticle labels |
DE102006000775A1 (en) * | 2006-01-04 | 2007-07-12 | Julius-Maximilians-Universität Würzburg | Diagnostic imaging techniques, useful for representing distribution of substances in immobilized cell, comprises displacing immobilized cell with a substance and bonding a marker for surface enhanced vibrational spectroscopy on substance |
EP1977242B1 (en) * | 2006-01-27 | 2016-08-03 | Becton Dickinson and Company | Lateral flow immunoassay with encapsulated detection modality |
EP3241838A1 (en) * | 2006-02-08 | 2017-11-08 | Becton Dickinson and Company | Sers nanotag assays |
US20090280188A1 (en) * | 2006-06-23 | 2009-11-12 | Northwestern University | Asymmetric functionalizated nanoparticles and methods of use |
ES2422295T5 (en) * | 2006-07-24 | 2017-06-15 | Becton Dickinson And Company | Apparatus and method for performing an assay using magnetic particles |
US20090047673A1 (en) * | 2006-08-22 | 2009-02-19 | Cary Robert B | Miniaturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids |
US7502106B2 (en) * | 2006-09-21 | 2009-03-10 | Honeywell International Inc. | SERS analyzer |
US7727776B2 (en) * | 2006-10-24 | 2010-06-01 | Honeywell International Inc. | Core-shell nanoparticles for detection based on SERS |
EP2104742B1 (en) * | 2006-11-21 | 2014-05-07 | Jawaharlal Nehru Centre for Advanced Scientific Research | A high sensitivity assay for molecular typing of biological sample, probes and a kit thereof |
US7763511B2 (en) * | 2006-12-29 | 2010-07-27 | Intel Corporation | Dielectric barrier for nanocrystals |
US7869030B2 (en) * | 2007-01-03 | 2011-01-11 | Research Foundation Of State University Of New York | Aggregates of plural transition metal nanoparticles and plural cyanine dye molecules |
US8343627B2 (en) | 2007-02-20 | 2013-01-01 | Research Foundation Of State University Of New York | Core-shell nanoparticles with multiple cores and a method for fabricating them |
US20090017562A1 (en) * | 2007-03-13 | 2009-01-15 | Iowa State University Research Foundation, Inc. | Raman-active reagents |
MX2009009994A (en) | 2007-03-20 | 2009-10-19 | Becton Dickinson Co | Assays using surface-enhanced raman spectroscopy (sers)-active particles. |
EP1992938A1 (en) * | 2007-05-14 | 2008-11-19 | Koninklijke Philips Electronics N.V. | Improved methods of SE(R)RS detection using multiple labels |
US8367506B2 (en) * | 2007-06-04 | 2013-02-05 | Micron Technology, Inc. | High-k dielectrics with gold nano-particles |
US20120164717A1 (en) * | 2007-07-18 | 2012-06-28 | Joseph Irudayaraj | Identity profiling of cell surface markers |
EP2173820A2 (en) * | 2007-07-24 | 2010-04-14 | Northwestern University | Coated colloidal materials |
EP2040075A1 (en) | 2007-09-24 | 2009-03-25 | Julius-Maximilians-Universität Würzburg | Compounds and markers for surface-enhanced raman scattering |
ITPO20070023A1 (en) | 2007-09-26 | 2009-03-27 | Hospitex Diagnostics S R L | METHOD AND DEVICE FOR THE HIGH SENSITIVITY MULTIPLE ANALYSIS OF BIOLOGICAL SAMPLES |
US7829735B2 (en) * | 2007-10-26 | 2010-11-09 | Northwestern University | Universal phosphoramidite for preparation of modified biomolecules and surfaces |
WO2009086509A2 (en) * | 2007-12-27 | 2009-07-09 | Purdue Research Foundation | Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy |
EP2227681A4 (en) * | 2007-12-31 | 2011-01-12 | Univ California | Sers-based, single step, real-time detection of protein kinase and/or phosphatase activity |
CN101978072A (en) * | 2008-01-14 | 2011-02-16 | 超快纳米诊断公司 | Rapid test including genetic sequence probe |
US20100105024A1 (en) * | 2008-01-14 | 2010-04-29 | Transgenex Nanobiotech, Inc. | Rapid test including genetic sequence probe |
US20100279272A1 (en) * | 2008-02-13 | 2010-11-04 | Michael Craig Burrell | Multiplexed analysis methods using sers-active nanoparticles |
US20090253121A1 (en) * | 2008-04-04 | 2009-10-08 | Micah Halpern | Method for amt-rflp dna fingerprinting |
WO2009137059A1 (en) | 2008-05-05 | 2009-11-12 | Los Alamos National Security, Llc | Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control |
US20160266104A1 (en) * | 2008-05-07 | 2016-09-15 | Korea Research Institute Of Chemical Technology | Heterodimeric core-shell nanoparticle in which raman-active molecules are located at a binding portion of a nanoparticle heterodimer, use thereof, and method for preparing same |
KR101153748B1 (en) * | 2008-05-07 | 2012-06-14 | 재단법인서울대학교산학협력재단 | NOVEL Au/Ag CORE SHELL COMPOSITE USEFUL FOR BIOSENNOVEL Au/Ag CORE SHELL COMPOSITE USEFUL FOR BIOSENSOR SOR |
EP2352999A4 (en) * | 2008-10-15 | 2012-12-26 | Univ Cornell | Enhanced on-chip sers based biomolecular detection using electrokinetically active microwells |
US7879625B1 (en) | 2008-12-03 | 2011-02-01 | The United States Of America As Represented By The Secretary Of The Navy | Preparation of SERS substrates on silica-coated magnetic microspheres |
US20110171749A1 (en) * | 2009-03-02 | 2011-07-14 | Board Of Trustees Of Michigan State University | Nanoparticle tracer-based electrochemical dna sensor for detection of pathogens-amplification by a universal nano-tracer (aunt) |
JP5391744B2 (en) * | 2009-03-09 | 2014-01-15 | 住友ベークライト株式会社 | Array substrate |
US20100291599A1 (en) * | 2009-05-18 | 2010-11-18 | Bruker Optics, Inc. | Large area scanning apparatus for analyte quantification by surface enhanced raman spectroscopy and method of use |
US9046526B2 (en) * | 2009-06-12 | 2015-06-02 | Agency For Science, Technology And Research | Method for determining protein-nucleic acid interaction |
DE102009050287B4 (en) | 2009-10-20 | 2012-07-05 | Friedrich-Schiller-Universität Jena | SERS substrate |
US9575061B2 (en) * | 2009-10-20 | 2017-02-21 | Vanderbilt University | Liquid drop diagnostic assays |
CA2783788C (en) * | 2009-12-11 | 2015-02-10 | Korea Research Institute Of Chemical Technology | Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same |
EP2516995B1 (en) * | 2009-12-22 | 2016-10-26 | Agency For Science, Technology And Research | Sers-based analyte detection |
US8416609B2 (en) | 2010-02-15 | 2013-04-09 | Micron Technology, Inc. | Cross-point memory cells, non-volatile memory arrays, methods of reading a memory cell, methods of programming a memory cell, methods of writing to and reading from a memory cell, and computer systems |
FR2963106A1 (en) * | 2010-07-21 | 2012-01-27 | Ecole Polytechnique Dgar | METHOD AND DEVICE FOR ANALYZING MOLECULAR INTERACTIONS, AND USES THEREOF |
KR101229991B1 (en) | 2010-10-06 | 2013-02-05 | 단국대학교 산학협력단 | Simultaneous measuring sensor system of LSPR and SERS signal based on optical fiber |
PT2699698T (en) | 2011-04-20 | 2017-04-11 | Mesa Biotech Inc | Oscillating amplification reaction for nucleic acids |
GB201207821D0 (en) * | 2012-04-05 | 2012-06-13 | Renishaw Diagnostics Ltd | Dye sets for surface enhanced resonant raman spectroscopy |
KR101460439B1 (en) * | 2012-05-14 | 2014-11-12 | 서울대학교산학협력단 | Nanoprobe and method for detecting target substance using the same |
CN102692405B (en) * | 2012-06-07 | 2015-05-27 | 中国科学院合肥物质科学研究院 | Rice-grain-shaped fluoride/silver composite nanometer material and preparation method and application thereof |
CA2882003C (en) * | 2012-08-17 | 2020-11-10 | Japan Science And Technology Agency | Method and apparatus for analyzing biomolecules using raman spectroscopy |
US9512468B2 (en) | 2012-11-06 | 2016-12-06 | Industrial Technology Research Institute | Detection method uses magnetic and detectable nanoparticles with oligonucleotides attached thereto |
EP2932243B1 (en) * | 2012-12-11 | 2020-05-13 | Zamecnik, Colin R. | Encapsulated dye coated noble metal nanoparticles with increased surface enhanced raman scattering properties as contrast agents |
US10001478B2 (en) | 2013-08-21 | 2018-06-19 | Mycartis Nv | Heterogenous surface functionalization |
US10961564B2 (en) | 2014-05-28 | 2021-03-30 | University Of Houston System | Nanoporous gold and silver nanoparticles and substrates for molecular and biomolecular sensing |
CN104142375B (en) * | 2014-08-20 | 2016-01-20 | 中华人民共和国潍坊出入境检验检疫局 | A kind ofly utilize mould metabolic product to set up finger-print and utilize the method for fingerprint identification mold species |
BR112017005121A2 (en) | 2014-09-23 | 2018-07-31 | Tearlab Res Inc | systems and methods for integrating microfluidic tear collection and lateral flow analysis of analytes of interest. |
EP3001183B1 (en) * | 2014-09-25 | 2019-02-13 | Centre National De La Recherche Scientifique (Cnrs) | Detection of analytes using nanoparticles as light scattering enhancers |
US10105080B1 (en) * | 2014-10-24 | 2018-10-23 | Verily Life Sciences Llc | Interstitial fluid sampling above microneedle array |
JP2016156807A (en) * | 2015-02-23 | 2016-09-01 | 株式会社堀場製作所 | Analysis method and analysis device |
JP6582046B2 (en) * | 2015-05-29 | 2019-09-25 | 京セラ株式会社 | Detection method and detection apparatus |
US10392598B2 (en) | 2015-06-19 | 2019-08-27 | Emory University | Methods of measuring cell purity for making quality control determinations and related compositions |
US10301667B2 (en) * | 2015-11-18 | 2019-05-28 | University Of Florida Research Foundation, Inc. | Devices for detecting target biological molecules from cells and viruses |
CN106596927B (en) * | 2016-12-26 | 2018-10-19 | 中国科学院长春光学精密机械与物理研究所 | A kind of optical fiber bio probe and preparation method thereof and whole blood test method |
EP3593137A1 (en) | 2017-03-10 | 2020-01-15 | Universität Duisburg-Essen | Efficient ligand exchange of a detergent bilayer on the surface of metal nanoparticles for molecular functionalization and assembly, corresponding functionalized nanoparticles and nanoparticle assemblies, and their use in plasmonic applications including surface-enhanced raman spectroscopy |
US10156658B1 (en) * | 2017-06-06 | 2018-12-18 | Saudi Arabian Oil Company | Detecting a tracer in a hydrocarbon reservoir |
JP2020525038A (en) * | 2017-06-30 | 2020-08-27 | コリア リサーチ インスティテュート オブ ケミカル テクノロジー | Sepsis diagnostic kit and diagnostic method using the same |
CN110554018A (en) * | 2018-05-31 | 2019-12-10 | 上海市刑事科学技术研究院 | Surface enhanced Raman material for detecting 4-bromomethcathinone in aqueous solution and preparation method thereof |
CN110951833B (en) * | 2018-09-26 | 2022-03-29 | 中国农业大学 | Detection kit and detection method for simultaneously detecting drift or deposition of multiple spraying droplets |
JPWO2020203969A1 (en) * | 2019-04-03 | 2020-10-08 | ||
GB201907007D0 (en) * | 2019-05-17 | 2019-07-03 | Nano Biosols Ltd | A simple method and kit for quantifying gold nanoparticles in a liquid sample |
CN110455754B (en) * | 2019-07-15 | 2022-03-18 | 深圳大学 | DNA probe and manufacturing method thereof |
CN110749585B (en) * | 2019-09-11 | 2022-04-01 | 亳州市新健康科技有限公司 | Biosensor based on surface enhanced Raman technology and preparation method thereof |
CN110646399B (en) * | 2019-09-29 | 2021-08-13 | 吉林大学 | SERS-based high-throughput protein detection chip |
CN110702665B (en) * | 2019-11-14 | 2022-03-22 | 济南大学 | Preparation of paper-based coupling enhanced Raman sensor and application of paper-based coupling enhanced Raman sensor in okadaic acid detection |
JPWO2021193589A1 (en) * | 2020-03-23 | 2021-09-30 | ||
GB202017378D0 (en) * | 2020-11-02 | 2020-12-16 | Univ Birmingham | Single point variant detection |
CN112698020B (en) * | 2020-11-12 | 2022-08-26 | 中山大学 | Multimodal coupling analysis method of cross response system based on DNA-AuNP coding |
CN113433100B (en) * | 2021-05-25 | 2022-09-27 | 上海市公共卫生临床中心 | Plasma tryptophan and albumin joint detection method based on photochemical reaction of DNA synthesized silver nanoclusters and tryptophan |
US11796517B2 (en) | 2021-11-09 | 2023-10-24 | Saudi Arabian Oil Company | Multifunctional magnetic tags for mud logging |
US11725139B2 (en) | 2021-12-13 | 2023-08-15 | Saudi Arabian Oil Company | Manipulating hydrophilicity of conventional dye molecules for water tracer applications |
WO2023205784A2 (en) * | 2022-04-21 | 2023-10-26 | Emory University | Heteromultivalent nucleic acid functionalized materials to detect mutations and use in diagnostic applications |
KR20230165011A (en) * | 2022-05-26 | 2023-12-05 | 단국대학교 산학협력단 | Digital localized surface plasmon resonance sensor using optical fiber bundle and manufacturing method |
CN115855928A (en) * | 2023-02-27 | 2023-03-28 | 合肥工业大学 | Mercury ion detection method and kit based on nucleic acid macroarray and bifunctional molecules |
Family Cites Families (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193983A (en) * | 1978-05-16 | 1980-03-18 | Syva Company | Labeled liposome particle compositions and immunoassays therewith |
NL7807532A (en) * | 1978-07-13 | 1980-01-15 | Akzo Nv | METAL IMMUNO TEST. |
US4318707A (en) * | 1978-11-24 | 1982-03-09 | Syva Company | Macromolecular fluorescent quencher particle in specific receptor assays |
US4256834A (en) * | 1979-04-09 | 1981-03-17 | Syva Company | Fluorescent scavenger particle immunoassay |
US4261968A (en) * | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4650770A (en) * | 1981-04-27 | 1987-03-17 | Syntex (U.S.A.) Inc. | Energy absorbing particle quenching in light emitting competitive protein binding assays |
US4713348A (en) * | 1983-04-05 | 1987-12-15 | Syntex (U.S.A.) Inc. | Fluorescent multiparameter particle analysis |
US5288609A (en) * | 1984-04-27 | 1994-02-22 | Enzo Diagnostics, Inc. | Capture sandwich hybridization method and composition |
US4868104A (en) * | 1985-09-06 | 1989-09-19 | Syntex (U.S.A.) Inc. | Homogeneous assay for specific polynucleotides |
US4996143A (en) * | 1985-12-23 | 1991-02-26 | Syngene, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization |
US5137827A (en) * | 1986-03-25 | 1992-08-11 | Midwest Research Technologies, Inc. | Diagnostic element for electrical detection of a binding reaction |
US5514602A (en) * | 1986-06-09 | 1996-05-07 | Ortho Diagnostic Systems, Inc. | Method of producing a metal sol reagent containing colloidal metal particles |
US5360895A (en) * | 1987-04-22 | 1994-11-01 | Associated Universities, Inc. | Derivatized gold clusters and antibody-gold cluster conjugates |
US4853335A (en) * | 1987-09-28 | 1989-08-01 | Olsen Duane A | Colloidal gold particle concentration immunoassay |
GB8800702D0 (en) | 1988-01-13 | 1988-02-10 | Nycomed As | Test method & reagent kit therefor |
WO1990002205A1 (en) | 1988-08-25 | 1990-03-08 | Angenics, Inc. | Detection of nucleic acid sequences using particle agglutination |
DE3901458A1 (en) * | 1989-01-19 | 1990-07-26 | Behringwerke Ag | USE OF TWO OR THREE-VALUE CATIONS IN IMMUNCHEMICAL TESTS |
US5266498A (en) * | 1989-10-27 | 1993-11-30 | Abbott Laboratories | Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal |
US5376556A (en) * | 1989-10-27 | 1994-12-27 | Abbott Laboratories | Surface-enhanced Raman spectroscopy immunoassay |
US5460831A (en) * | 1990-06-22 | 1995-10-24 | The Regents Of The University Of California | Targeted transfection nanoparticles |
WO1992008133A1 (en) * | 1990-10-29 | 1992-05-14 | Dekalb Plant Genetics | Isolation of biological materials using magnetic particles |
US5665582A (en) * | 1990-10-29 | 1997-09-09 | Dekalb Genetics Corp. | Isolation of biological materials |
US5294369A (en) * | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
US5203989A (en) * | 1991-01-30 | 1993-04-20 | Reidy James J | Portable air-water generator |
JPH07502479A (en) * | 1991-11-22 | 1995-03-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Semiconductor microcrystals covalently bonded to solid inorganic surfaces using self-assembled monolayers |
US5225064A (en) * | 1992-01-15 | 1993-07-06 | Enzyme Technology Research Group, Inc. | Peroxidase colloidal gold oxidase biosensors for mediatorless glucose determination |
US5306403A (en) * | 1992-08-24 | 1994-04-26 | Martin Marietta Energy Systems, Inc. | Raman-based system for DNA sequencing-mapping and other separations |
US5472881A (en) * | 1992-11-12 | 1995-12-05 | University Of Utah Research Foundation | Thiol labeling of DNA for attachment to gold surfaces |
US5637508A (en) * | 1993-03-26 | 1997-06-10 | Geo-Centers, Inc. | Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same |
US5384265A (en) * | 1993-03-26 | 1995-01-24 | Geo-Centers, Inc. | Biomolecules bound to catalytic inorganic particles, immunoassays using the same |
US5681943A (en) * | 1993-04-12 | 1997-10-28 | Northwestern University | Method for covalently linking adjacent oligonucleotides |
EP0630974A3 (en) | 1993-06-25 | 1995-11-15 | Clinical Diagnostic Syst | Method and test kit for the detection of inorganic orthophosphate by-product from amplification of target nucleic acid. |
US5543158A (en) * | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
JPH07227299A (en) | 1994-02-14 | 1995-08-29 | Kyoto Daiichi Kagaku:Kk | Method for detecting specific base sequence of dna and device therefor |
US5521289A (en) * | 1994-07-29 | 1996-05-28 | Nanoprobes, Inc. | Small organometallic probes |
US5599668A (en) * | 1994-09-22 | 1997-02-04 | Abbott Laboratories | Light scattering optical waveguide method for detecting specific binding events |
US6025202A (en) * | 1995-02-09 | 2000-02-15 | The Penn State Research Foundation | Self-assembled metal colloid monolayers and detection methods therewith |
US5609907A (en) * | 1995-02-09 | 1997-03-11 | The Penn State Research Foundation | Self-assembled metal colloid monolayers |
GB9517955D0 (en) * | 1995-07-25 | 1995-11-08 | Univ Strathclyde | Nucleotide sequence detection and analysis |
US5814516A (en) * | 1995-10-13 | 1998-09-29 | Lockheed Martin Energy Systems, Inc. | Surface enhanced Raman gene probe and methods thereof |
BR9710836A (en) * | 1996-04-25 | 2000-10-24 | Spectrametrix Inc | Analyte assay using particle marks |
US6506564B1 (en) * | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6582921B2 (en) * | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
US6361944B1 (en) * | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6750016B2 (en) * | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
ES2287956T3 (en) | 1996-07-29 | 2007-12-16 | Nanosphere Inc. | NANOPARTICLES THAT HAVE OLIGONUCLEOTIDES UNITED TO THE SAME AND USES OF THE SAME. |
US7169556B2 (en) * | 1996-07-29 | 2007-01-30 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6984491B2 (en) * | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
WO1998010289A1 (en) | 1996-09-04 | 1998-03-12 | The Penn State Research Foundation | Self-assembled metal colloid monolayers |
US5830986A (en) * | 1996-10-28 | 1998-11-03 | Massachusetts Institute Of Technology | Methods for the synthesis of functionalizable poly(ethylene oxide) star macromolecules |
US5900481A (en) * | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
US5922537A (en) * | 1996-11-08 | 1999-07-13 | N.o slashed.AB Immunoassay, Inc. | Nanoparticles biosensor |
US5939021A (en) * | 1997-01-23 | 1999-08-17 | Hansen; W. Peter | Homogeneous binding assay |
US6974669B2 (en) * | 2000-03-28 | 2005-12-13 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified nanoparticles |
US6149868A (en) * | 1997-10-28 | 2000-11-21 | The Penn State Research Foundation | Surface enhanced raman scattering from metal nanoparticle-analyte-noble metal substrate sandwiches |
US5990479A (en) * | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US5972615A (en) * | 1998-01-21 | 1999-10-26 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US6290839B1 (en) * | 1998-06-23 | 2001-09-18 | Clinical Micro Sensors, Inc. | Systems for electrophoretic transport and detection of analytes |
US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6251303B1 (en) * | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
US6306610B1 (en) * | 1998-09-18 | 2001-10-23 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
US6203989B1 (en) | 1998-09-30 | 2001-03-20 | Affymetrix, Inc. | Methods and compositions for amplifying detectable signals in specific binding assays |
DE69936534T2 (en) | 1998-11-30 | 2008-03-13 | Nanosphere, Inc., Northbrook | NANOPARTICLES WITH POLYMERSHOLES |
US6277489B1 (en) * | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
ATE502117T1 (en) * | 1999-06-25 | 2011-04-15 | Nanosphere Inc | NANOPARTICLES WITH BONDED OLIGONUCLEOTIDES AND USES THEREOF |
CA2396113C (en) | 2000-01-13 | 2009-04-07 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
JP2004515208A (en) | 2000-03-28 | 2004-05-27 | ナノスフェアー インコーポレイテッド | Oligonucleotide-attached nanoparticles and methods of use |
ATE324465T1 (en) * | 2000-07-11 | 2006-05-15 | Univ Northwestern | DETECTION METHOD USING INCREASED SILVER TINTING |
AU2001281248A1 (en) | 2000-08-11 | 2002-03-13 | Nanosphere Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US7829348B2 (en) * | 2000-09-22 | 2010-11-09 | Iowa State University Research Foundation, Inc. | Raman-active reagents and the use thereof |
WO2002046483A2 (en) * | 2000-12-06 | 2002-06-13 | Northwestern University | Silver stain removal from dna detection chips by cyanide etching or sonication |
WO2002046475A2 (en) | 2000-12-08 | 2002-06-13 | Curagen Corporation | Method of detecting and treating tuberous sclerosis complex associated disorders |
EP1356109A2 (en) | 2000-12-08 | 2003-10-29 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
EP1379693B1 (en) | 2001-03-28 | 2009-05-20 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified particles |
AU2002367709A1 (en) | 2001-04-26 | 2003-10-27 | Nanosphere, Inc. | Oligonucleotide-modified romp polymers and co-polymers |
US20030113740A1 (en) * | 2001-04-26 | 2003-06-19 | Mirkin Chad A. | Oligonucleotide-modified ROMP polymers and co-polymers |
US7238472B2 (en) | 2001-05-25 | 2007-07-03 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
US7147687B2 (en) * | 2001-05-25 | 2006-12-12 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
EP1412536B1 (en) * | 2001-08-03 | 2009-02-25 | Nanosphere, Inc. | Nanoparticle imaging system and method |
AU2002363062B2 (en) | 2001-10-09 | 2007-03-22 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US7186814B2 (en) * | 2001-11-09 | 2007-03-06 | Nanosphere, Inc. | Bioconjugate-nanoparticle probes |
US20030211488A1 (en) | 2002-05-07 | 2003-11-13 | Northwestern University | Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection |
AU2003247788B2 (en) * | 2002-07-02 | 2007-04-19 | Nanosphere Inc. | Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
EP1583948B1 (en) * | 2002-11-26 | 2010-09-01 | University of Maryland Biotechnology | High-sensitivity assays for pathogen detection using metal-enhanced fluorescence |
WO2004053105A2 (en) | 2002-12-12 | 2004-06-24 | Nanosphere, Inc. | Direct snp detection with unamplified dna |
US7361410B2 (en) * | 2003-12-29 | 2008-04-22 | Intel Corporation | External modification of composite organic inorganic nanoclusters comprising raman active organic compound |
-
2002
- 2002-06-14 US US10/172,428 patent/US20030211488A1/en not_active Abandoned
-
2003
- 2003-05-07 AT AT03736550T patent/ATE515698T1/en not_active IP Right Cessation
- 2003-05-07 AU AU2003237180A patent/AU2003237180B2/en not_active Ceased
- 2003-05-07 WO PCT/US2003/014100 patent/WO2003095973A2/en active IP Right Grant
- 2003-05-07 EP EP03736550A patent/EP1499889B1/en not_active Expired - Lifetime
- 2003-05-07 CA CA2483697A patent/CA2483697C/en not_active Expired - Fee Related
- 2003-05-07 JP JP2004503919A patent/JP2005524849A/en active Pending
- 2003-05-07 US US10/431,341 patent/US7985539B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2003095973A3 (en) | 2004-07-22 |
EP1499889B1 (en) | 2011-07-06 |
EP1499889A4 (en) | 2006-11-08 |
WO2003095973A2 (en) | 2003-11-20 |
AU2003237180A1 (en) | 2003-11-11 |
US20040086897A1 (en) | 2004-05-06 |
AU2003237180B2 (en) | 2007-05-24 |
US20030211488A1 (en) | 2003-11-13 |
US7985539B2 (en) | 2011-07-26 |
EP1499889A2 (en) | 2005-01-26 |
CA2483697C (en) | 2010-03-30 |
JP2005524849A (en) | 2005-08-18 |
ATE515698T1 (en) | 2011-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2483697A1 (en) | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection | |
CA2490413C (en) | Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes | |
Wang et al. | Gold nanoparticle probes | |
JP4630345B2 (en) | Enhanced multiplexed signal detection by surface enhanced Raman spectroscopy (SERS) | |
EP2038656B1 (en) | Ultra-sensitive detection of analytes | |
US20230213507A1 (en) | Optical probe for bio-sensor, optical bio-sensor including optical probe, and method for manufacturing optical probe for bio-sensor | |
EP1639370B1 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes | |
US20050250094A1 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes | |
EP1992938A1 (en) | Improved methods of SE(R)RS detection using multiple labels | |
US20070155020A1 (en) | Detection of chemical analytes by array of surface enhanced Raman scattering reactions | |
JP2007524087A (en) | Methods and apparatus for using Raman-active probe constructs to assay biological samples | |
CN101467045A (en) | Increased specificity of analyte detection by measurement of bound and unbound labels | |
US20080081340A1 (en) | Enzymatic and chemical method for increased peptide detection sensitivity using surface enhanced raman scattering (SERS) | |
US20130065780A1 (en) | Label-Free Multiplexing Bioassays Using Fluorescent Conjugated Polymers and Barcoded Nanoparticles | |
AU2007211939A1 (en) | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection | |
WO2007044025A9 (en) | Method for detecting analytes based on evanescent illumination and scatter-based detection of nonoparticle probe complexes | |
US20140287949A1 (en) | Multiplex assay for members of binding pairs | |
US20050176064A1 (en) | Method for determining the number of receptors on a carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20200831 |